Pharma giant AstraZeneca ups its India game with a Rs 250 crore investment! This tech hub expansion promises a surge…
The Covishield controversy centers on rare instances of blood clot disorders reported in some individuals following vaccination, raising global concern…
The Israeli Ministry of Health has approved the use of AstraZeneca's Evusheld Covid-19 medication in patients with compromised immune systems.…
The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in…
According to specialists, the Lancet article, which claims that the protection provided by the Oxford AstraZeneca COVID-19 vaccine Covishield diminishes…
According to a new study from the University of Oxford, a booster dose of the AstraZeneca coronavirus vaccine significantly increased…
According to a peer-reviewed study, Omicron can circumvent the immunological protection provided by COVID-19 vaccines as well as natural infection,…
According to the findings of a large British trial on the combination of COVID-19 vaccinations, participants had a greater immune…
If this variant is five times more lethal than the Delta variant and causes lower fatalities, it will prove to…
Following a series of setbacks during the pandemic, AstraZeneca announced on Tuesday that it is forming a separate division for…